| Group T(n = 44) | Group N(n = 44) | t | P |
---|---|---|---|---|
CD3+P+(%) | 8.93 ± 1.07 | 12.55 ± 1.71 | -2.466 | 0.018* |
CD3+G+(%) | 20.8 ± 2.03 | 20.78 ± 2.71 | 0.01 | 0.992 |
CD8+P+(%) | 8.75 ± 1.01 | 9.13 ± 1.07 | -0.293 | 0.771 |
CD8+G+(%) | 28.36 ± 2.28 | 20.21 ± 1.61 | 3.719 | 0.001* |
CD16-CD56+P+(%) | 29.35 ± 2.94 | 35.13 ± 3.66 | -1.839 | 0.073 |
CD16-CD56+G+(%) | 30.87 ± 2.81 | 33.69 ± 3.6 | -1.159 | 0.253 |